Melas Syndrome


Article Author:
Shermila Pia


Article Editor:
Forshing Lui


Editors In Chief:
Jon Parham
Abigail Frank
Jon Sivoravong


Managing Editors:
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Frank Smeeks
Kristina Soman-Faulkner
Benjamin Eovaldi
Radia Jamil
Sobhan Daneshfar
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Hajira Basit
Phillip Hynes
Kavin Sugumar


Updated:
1/16/2019 10:02:35 AM

Introduction

Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial disease primarily affecting the nervous system and muscles. MELAS presents in children or young adults as recurrent episodes of encephalopathy, myopathy, headache, and focal neurological deficits. The condition is relentlessly progressive, resulting in neurological impairment by adolescence or early adulthood.

Etiology

MELAS is a mitochondrial inherited genetic disorder. Paternal mitochondria are present only in the tailpiece of the sperms. As a result, they are lost during fertilization and mitochondrial disorders including MELAS are maternally inherited. In rare instances, MELAS may result from a sporadic mutation with no family history. Mitochondrial genetic disorders are the result of mutations causing impaired mitochondrial function, including oxidative phosphorylation and energy production. In MELAS, mutations in tRNA are believed to cause impairment of protein assembly into respiratory chain complexes, though the exact mechanisms have yet to be elucidated. Mitochondria are the powerhouse of cells. Any mitochondrial disorder will affect the most metabolically active organs of the body especially the brain and muscles.

Many different transfer RNA (tRNA) mutations can cause MELAS. The most common mutation is in the MTTL1 mitochondrial gene. A single base pair mutation, m.3243A>G, is found in 80% patients, and a second common mutation, m.3271T>C, is found in 10%.[1][2] However, many other genes are being identified with similar phenotypic syndromes such as POLG and BCS1L.

The neurological symptoms of MELAS are believed to result from a combination of impaired mitochondrial energy production, microvascular angiopathy, and nitric oxide deficiency, which may cause impaired cerebral vasodilation.[3]

Epidemiology

MELAS is one of the most common mitochondrial diseases, with an estimated incidence of 1 in 4000.

Both genders are equally affected, but only women can pass the condition on as mitochondria are carried in the tails of sperm cells and therefore shed outside the zygote during fertilization.

Pathophysiology

Each somatic cell possesses multiple and variable copies of the same mitochondrial DNA or genome. This mitochondrial DNA is also damaged to different degrees with the aging of cells. Like any mitochondrial disorder, MELAS exhibits heteroplasmy or a variation in the types of mitochondrial DNA found in different tissues in the same person. It is common for genetic mutations only to affect some mitochondria, which leads to a variable appearance of diseased mitochondria in different tissues in the same person. This phenomenon explains the wide variability in the presentation of different tissues within an individual and also presentation among different patients with the same diagnosis. This also has implications for diagnosis, as occasionally serum and urine studies may be negative if those cell lines are unaffected, making it necessary to perform muscle biopsy to examine affected tissue.

Mitochondrial disorders including MELAS affect mainly tissues with the highest metabolic activities. These include skeletal and heart muscles, brain, eye, and the inner ear. Due to the impaired mitochondrial respiratory chain function and oxidative phosphorylation, the increased anaerobic glycolytic activities will lead to increased lactic acid during acute attacks.

Histopathology

The hallmark of mitochondrial disease is an accumulation of mitochondria in muscle fibers visualized on Gomori trichrome stain. The diseased mitochondria proliferate in an attempt to compensate for poor energy production and appear bright red compared to the blue myofibers, therefore called "ragged red fibers." MELAS also shows strongly succinate dehydrogenase (SDH)-reactive blood vessels due to mitochondrial proliferation in perivascular smooth muscle and endothelial cells.

History and Physical

Children with MELAS often have normal early psychomotor development until the onset of symptoms between 2 and 10 years old. Though less common, infantile onset may occur and may present as failure to thrive, growth retardation and progressive deafness. Onset in older children typically presents as recurrent attacks of a migraine-like headache, anorexia, vomiting, and seizures. Children with MELAS are also frequently found to have short stature.

Myopathy in MELAS initially presents as exercise intolerance or proximal muscle weakness. Due to the severity of the other neurological features, the myopathy is often under-recognized. The myopathy in MELAS often does not cause a significant functional disturbance.

Seizures in MELAS may be focal or generalized and have no recognized syndrome-specific semiology or EEG findings. Children with younger age of onset tend to have higher rates of drug-resistance epilepsy and therefore more severe clinical dysfunction.

Seizures are often accompanied by sudden focal neurological deficits which are termed "stroke-like episodes." These episodes differ from a typical stroke in that they do not conform to any vascular territory, the MRI findings may fluctuate or resolve more quickly than typical stroke, and the apparent diffusion coefficient on MRI is not always decreased like typical infarct, and may instead be increased or mixed. Typical focal neurologic deficits include hemiparesis, hemianopia, or aphasia. Residual deficits from stroke-like episodes gradually impair neurologic function. By adolescence or young adulthood, patients often have impaired motor function, vision, mentation, and sensorineural hearing loss.

Encephalopathy is another key feature. Altered level of consciousness is often associated with the stroke-like episodes. Mental deterioration begins during childhood and is slowly progressive.

Other organ systems may also be involved in MELAS. Patients are reported to have cardiac conduction disorders, diabetes, and chronic fatigue.

Evaluation

MRI: Multifocal infarct-like cortical areas in different stages of ischemic evolution, areas that do not conform to any known vascular territory. Initial lesions often occur in the occipital or parietal lobes with eventual involvement of the cerebellum, cerebral cortex, basal ganglia, and thalamus.

Lactate is often elevated in serum and cerebrospinal fluid (CSF). MR spectroscopy may show an elevated lactate peak in affected and even unaffected brain areas.

Muscle biopsy shows ragged red fibers. However, genetic evaluation should be done first, which eliminates the need for muscle biopsy in most cases.

Diagnosis may be molecular or clinical:

  1. Stroke-like episodes before 40 years old
  2. Encephalopathy with seizures or dementia
  3. Blood lactic acidosis* or ragged red fibers on muscle biopsy

*Due to mitochondrial heteroplasmy, urine and blood testing is preferable to blood alone

Treatment / Management

There is no treatment to stop disease progression.

Symptomatic treatment of seizures with anti-epileptic medications. There are several case reports of aggravation of MELAS epilepsy with use of Valproate, though the mechanisms behind this interaction are still being investigated.

Vitamins such as coenzyme Q10 or L-carnitine are thought to help increase energy production by mitochondria and may slow the effects of the disease. There are ongoing MELAS phase I and II trials of Idebenone, a synthetic coenzyme Q10, which has been shown to improve neurological function in other mitochondrial disorders (Scaglia, ClinicalTrials.gov Identifier: NCT00887562)

L-arginine has been shown to attenuate the severity of symptoms when used in acute attacks and decrease the frequency of episodes[4][3]. L-citrulline is also believed to be beneficial in recovery reduction of stroke risk. This relationship is theorized to be due to correction of nitric oxide deficiency in MELAS patients, as arginine and citrulline are precursors to nitric oxide production.

Differential Diagnosis

Other mitochondrial disorders should be considered in patients presenting with a family history concerning for maternal mitochondrial inheritance.

Kearns-Sayre is a rare neuromuscular disorder which also may present as visual disturbance, short stature, hearing loss, and ataxia. However, Kearns-Sayre is distinguished by its characteristic visual findings:

  • Chronic progressive external ophthalmoplegia
  • Atypical retinitis pigmentosa
  • Pigmentary degeneration of the retina

In addition to these visual findings, Kearns-Sayre patients often have cardiac manifestations which help distinguish these patients from MELAS patients.

Myoclonus epilepsy associated with ragged red fibers (MERRF) may be confused with MELAS as they both involve seizures, mental deterioration, and myopathy with ragged red fibers on biopsy. MERRF patients may also have hearing loss, visual disturbance secondary to optic atrophy, and short stature. The characteristic myoclonic seizure in MERRF may help to narrow diagnosis, but genetic testing should be considered to distinguish the 2 conditions.

Leigh syndrome may also present with progressive neurological deterioration, seizures, and vomiting mainly in young children.

Enhancing Healthcare Team Outcomes

Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial disease primarily affecting the nervous system and muscles. MELAS presents in children or young adults as recurrent episodes of encephalopathy, myopathy, headache, and focal neurological deficits. Because the condition is relentlessly progressive, resulting in neurological impairment by adolescence or early adulthood, it is best managed by a multidisciplinary team. In most patients the treatment is supportive but the overall prognosis is poor. It is important to get a social worker and physical therapy involved early in the course of the disease because these professionals can help improve the quality of life.[5][3][6][7][8]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Melas Syndrome - Questions

Take a quiz of the questions on this article.

Take Quiz
14-year-old girl is brought in with recurrent headaches and vomiting with transient right hemiparesis. She has had 3 episodes of tonic-clonic generalized seizures. Neurologic exam is normal. MRI shows bilateral subacute small vessel ischemic lesions. Lactic acid is elevated in the CSF and serum. What is the most likely diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 10-year-old female with a history of migraines presents with transient left-sided hemiparesis and altered consciousness lasting 10 minutes in the setting of a migraine. Prior migraines have been complex at times with a long history of left-sided sensory changes, but the patient has never before experienced weakness. Family history is significant for migraines and seizures. The patient's mother has a history of a stroke and early-onset dementia at age 42 years. The patient's exam is now normal. What is most likely to be seen on an MRI of the brain?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A previously healthy 5-year-old girl presents with acute onset headache, vomiting, encephalopathy, seizure, and right-sided hemiplegia. On further questioning, her parents report a similar episode a year prior which presented with sensorineural hearing loss which never fully returned to baseline. On exam, the patient is noted to have short stature. Workup for which mitochondrial disease should be included in the evaluation?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What are the treatment options for patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) disease?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
How do "stroke-like episodes" in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) differ from true ischemic stroke on MRI?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
An 8-year-old boy was recently diagnosed with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). Muscle biopsy is performed. What is likely to be reported on histology?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the typical inheritance pattern in mitochondrial encephalopathy lactic acidosis and stroke-like episodes (MELAS)?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Melas Syndrome - References

References

Niedermayr K,Pölzl G,Scholl-Bürgi S,Fauth C,Schweigmann U,Haberlandt E,Albrecht U,Zlamy M,Sperl W,Mayr JA,Karall D, Mitochondrial DNA mutation     [PubMed]
Ikeda T,Osaka H,Shimbo H,Tajika M,Yamazaki M,Ueda A,Murayama K,Yamagata T, Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome. Human genome variation. 2018     [PubMed]
Radelfahr F,Klopstock T, [Diagnostic and Therapeutic Approaches for Mitochondrial Diseases]. Fortschritte der Neurologie-Psychiatrie. 2018 Sep     [PubMed]
Koga Y,Povalko N,Inoue E,Nakamura H,Ishii A,Suzuki Y,Yoneda M,Kanda F,Kubota M,Okada H,Fujii K, Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research. Journal of neurology. 2018 Sep 29     [PubMed]
Brambilla A,Favilli S,Olivotto I,Calabri GB,Porcedda G,De Simone L,Procopio E,Pasquini E,Donati MA, Clinical profile and outcome of cardiac involvement in MELAS syndrome. International journal of cardiology. 2019 Feb 1;     [PubMed]
Finsterer J,Zarrouk-Mahjoub S, The heart in m.3243A>G carriers. Herz. 2018 Aug 20;     [PubMed]
Hirano M,Emmanuele V,Quinzii CM, Emerging therapies for mitochondrial diseases. Essays in biochemistry. 2018 Jul 20;     [PubMed]
Pérez Torre P,Acebrón-Herrera F,García Barragán N,Corral Corral Í, Global cerebral involvement and L-arginine use in a patient with MELAS syndrome. Neurologia (Barcelona, Spain). 2018 Jun 12;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Family Medicine. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Family Medicine, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Family Medicine, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Family Medicine. When it is time for the Family Medicine board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Family Medicine.